348 Épisodes

  1. Key Presentations on Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis from the 2020 ASH Annual Meeting with Dr Natalie Callander

    Publié: 02/04/2021
  2. Side Effects of Hormonal Therapy in Prostate Cancer with Dr Roberto Iacovelli

    Publié: 29/03/2021
  3. Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2020 ASH Annual Meeting with Dr Harry Erba

    Publié: 26/03/2021
  4. Management of CNS Metastases in Patients with Non-Small Cell Lung Cancer with Dr Manmeet Ahluwalia

    Publié: 23/03/2021
  5. Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma with Dr Gilles Salles

    Publié: 22/03/2021
  6. Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy with Dr Andrew Wei

    Publié: 19/03/2021
  7. PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín

    Publié: 12/03/2021
  8. Predictors of Response to Cancer Immunotherapy with Prof Solange Peters

    Publié: 12/03/2021
  9. Recently Approved Agents in Multiple Myeloma with Dr Joseph Mikhael

    Publié: 10/03/2021
  10. Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation with Dr Zofia Piotrowska

    Publié: 08/03/2021
  11. Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram

    Publié: 03/03/2021
  12. Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson

    Publié: 01/03/2021
  13. New Targets in Non-Small Cell Lung Cancer with Dr Justin Gainor

    Publié: 26/02/2021
  14. ER-Positive Metastatic Breast Cancer with Dr Erika Hamilton

    Publié: 24/02/2021
  15. Key Presentations on Chronic Lymphocytic Leukemia and Follicular Lymphoma from the 2020 ASH Annual Meeting with Dr Ann LaCasce

    Publié: 19/02/2021
  16. Current and Future Treatment Strategies for Advanced Ovarian Cancer with Dr Kathleen Moore 

    Publié: 19/02/2021
  17. Front-Line Treatment of Chronic Lymphocytic Leukemia with Dr Steven Coutre

    Publié: 16/02/2021
  18. Key Presentations on Myeloproliferative Neoplasms from the 2020 ASH Annual Meeting with Dr Aaron T Gerds

    Publié: 12/02/2021
  19. Newly Approved Agents in the Management of Urothelial Bladder Carcinoma with Dr Matthew Galsky

    Publié: 05/02/2021
  20. Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations with Dr Corey Langer

    Publié: 29/01/2021

15 / 18

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Visit the podcast's native language site